A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Alcohol
This training is designed for healthcare providers managing patients who use both alcohol and methamphetamines. Participants will explore evidence-informed strategies to mitigate risks and support safer patterns of use among individuals with co-occurring alcohol and methamphetamine consumption. The session emphasizes the mental health impacts of co-ingestion and examines how these effects influence clinical care. Participants will also review policy-level approaches that reduce associated risks and learn comprehensive treatment strategies, including pharmacotherapy and behavioral interventions, for managing co-occurring alcohol and methamphetamine use disorders.
 |
Monday, 12/22/2025 12:00 pm – 12:30 pm ET |
 |
This training fulfills the DEA's 8-hour training requirement for prescribers |
 |
Virtual event |
 |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Alcohol
This training is designed for healthcare providers managing patients who use both alcohol and MDMA. Participants will explore evidence-informed strategies to mitigate risks and support safer patterns of use among individuals with co-occurring alcohol and MDMA consumption. The session will review emerging research on the use of MDMA as a potential treatment adjunct for alcohol use disorder (AUD). Participants will also examine policy-level approaches that reduce risks associated with co-use and learn comprehensive treatment strategies, including pharmacotherapy and behavioral interventions, for managing co-occurring alcohol and MDMA-type use disorders.
|
Monday, 12/29/2025 12:00 pm – 12:30 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Alcohol
This training is designed to provide an introductory overview of alcohol use disorders. We will explore the latest epidemiological data, with a focus on the prevalence and trends of alcohol use and alcohol use disorders in the United States. Diagnostic criteria and screening tools to assess for alcohol use disorders will be discussed. Additionally, we will examine evidence-based interventions to treat alcohol use disorders and support individuals in their recovery.
|
Tuesday, 1/6/2026 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Stimulants
This training is a guide for addiction care teams caring for people who use stimulants, including cocaine and methamphetamines. The training will review the basic science of addiction related to stimulants and discuss the practical implementation of evidence-based treatment for patients who use stimulants, with a concentration on outpatient treatment settings.
|
Thursday, 1/22/2026 1:00 pm – 4:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training is designed to provide foundational knowledge and skills in initiating buprenorphine treatment for opioid use disorder in the outpatient setting in the context of the widespread presence of illicitly manufactured fentanyl. We explore how the potency and prevalence of fentanyl complicates the initiation phase of buprenorphine treatment, leading to potential clinical challenges such as precipitated withdrawal. We suggest participating in the next training in the series, Buprenorphine 201, upon completing Buprenorphine 101.
|
Friday, 1/23/2026 1:00 pm – 2:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: Alcohol
Many individuals experiencing mild alcohol withdrawal syndrome can be safely and successfully managed in the outpatient setting, allowing less interruption to one’s professional, family, and social obligations. This training will provide an overview of alcohol withdrawal assessment and management in an outpatient setting. Participants will be able to identify the signs and symptoms of alcohol withdrawal and appropriate candidates for outpatient withdrawal management. Validated tools to assess alcohol withdrawal will be reviewed and evidence-based medication management for outpatient alcohol withdrawal will be discussed.
|
Thursday, 2/19/2026 12:00 pm – 1:00 pm ET |
|
This training fulfills the DEA's 8-hour training requirement for prescribers |
|
Virtual event |
|
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.
© 2025 Boston Medical Center. All rights reserved. Site by Root802.